Skip to content
Catalyst

Elettaria cardamomumFinding

Elettaria cardamomum decreases HOMA-IR

lowersVery limited evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“Compared to the control group, a significant decrease in serum HbA1C (-0.4%), insulin (-2.8 µIU dL-1 ), HOMA-IR (-1.7) and TG (-39.9 mg dL-1 ), and an increase in SIRT1 (2.3 ng mL-1 ) was observed in cardamom group.”
Quoted verbatim from Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
This finding among the 76 findings on its endpoint

Elettaria cardamomum

HOMA-IR

lowers

Who
overweight or obese adults with type 2 diabetes mellitus
Dose studied
3 g/day green cardamom for 10 weeks

Very limited evidencePMID 30701554 · 2019

02 · The study

Study
RCT
Duration
2 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7KZ0Q79TC6GFM05V9ZE6FYJ